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Objective: With 99% of the cases in Brazil, malaria is endemic in the Amazon region.
Transfusion-transmitted malaria, an important risk in endemic areas, has been reported.
The aim of this study was to describe the epidemiological proﬁle of blood donor candidates
at the Fundac¸ão de Hematologia e Hemoterapia do Amazonas and evaluate the efﬁcacy of
rapid diagnostic tests used for malaria screening of blood donors within endemic regions.
Methods: Between May 2008 and May 2009, 407 blood donor candidates were selected and
grouped based on the Malaria Annual Parasite Index of the geographic area in which they
originated: Group 1 (eligible donors – n=265) originated from areas of low to medium risk
of exposure to malaria and Group 2 (ineligible donors – n=142) originated from high-risk
areas. All samples were concurrently screened using two immunochromatic antigen-based
rapid tests and by the thick smear test.
Results: All samples were negative by all three methods. The demographic proﬁle indicated
that the majority of participants were male, ages ranged from 18 to 39 years and less than
half the candidates had only elementary schooling. Two issues need to be addressed: one isthe ineligibility of donors and its impact on blood donor centers as, in this study, 22.7% of the
donors were considered ineligible. The other is the limited sensitivity of the parasitologicaltests used, allowing a risk of false-negative results.
∗ Corresponding author at: Fundac¸ão CECON, Diretoria de Ensino e Pesquisa, Rua Francisco Orellana, 215, Dom Pedro, 69040-010 Manaus,
M, Brazil.
E-mail address: katialuztorres@hotmail.com (K.L. Torres).
ttp://dx.doi.org/10.1016/j.bjhh.2014.05.002
516-8484/© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights
eserved.
270 rev bras hematol hemoter. 2014;36(4):269–274
Conclusion: Newmethods areneeded to ensure transfusion safetywithout rejectingpotential
donors, which would ensure safe transfusion without harming the blood supply.
© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
Vacutainer blood collection tube containing ethylenedi-Introduction
Malaria is an acute infectious febrile disease caused by proto-
zoan parasites from the genus Plasmodium.1 Malaria remains
a signiﬁcant public health problem around the world, result-
ing in more than one million deaths per year.2,3 In Brazil, the
infection is primarily caused by Plasmodium vivax and Plasmo-
dium falciparum; Plasmodium malariae transmission also occurs
but it is the least frequently diagnosed.1,2 The Amazon region
is the country’s endemic area accounting for 99% of the cases
diagnosed annually.4 Within the BrazilianAmazonRegion, the
distribution of cases is heterogeneous with risk of disease
transmission being based on the Annual Parasite Index (API),
calculated as the number of cases per 1000 inhabitants. High
risk transmission areas are those with an API ≥50 cases/1000
inhabitants, medium risk transmission areas have between 10
and 49 cases/1000 inhabitants and low risk transmission areas
are those with an API < 10 cases/1000 inhabitants.4
Natural transmission occurs by the bite of an infected
Anopheles sp.5 According to the Brazilian Ministry of Health
there are also possibilities of neonatal infection and accidents
with contaminated needles. Furthermore, transfusion-related
transmission is an important risk factor in endemic areas.6
Cases of malaria caused by blood transfusion can occur when
the donor has asymptomatic malaria or during the incuba-
tion period when the disease is not diagnosed by clinical and
epidemiological screening.7
Post-transfusion malaria represents a challenge to hema-
tology and hemotherapy centers located in the Amazon
Region as, according to Brazilian regulations, donors originat-
ing from endemic areas are classiﬁed as high risk for malaria
transmission and must be excluded. However, donors from
areas classiﬁed as medium to low risk of transmission are
allowed to donate blood, as long as parasitological tests have
been performed.8,9 The thick blood smear is considered the
gold standard to diagnose malaria; the test is based on micro-
scopic observation of the parasite. However, this method is
limited by its sensitivity and the need of well trained tech-
nicians and specialized materials.10 Even though the thick
smear is the most utilized method to diagnose malaria, it can-
not be performed as a high throughput test due to the impact
on the ﬂow of patient screening in hematology and hemother-
apy centers that need to process many patients per day; it is
thus unviable in endemic areas.10
The need to speed-up the screening and diagnostic pro-
cesses has resulted in the development of new technologies
to diagnose malaria including the immunochromatic antigen-
based rapid tests, or simply rapid tests. These tests are based
on the detection of monoclonal or polyclonal antibodies tar-
geting speciﬁc Plasmodium antigens on a nitrocellulose strip.11Previous studies have demonstrated that these tests usually
present low sensitivity when patients are asymptomatic and
with low parasite levels, posing a risk if administered in blood
donor screening.12
The control of malaria in endemic regions and trans-
fusion safety are important aspects to be considered. The
real incidence of transfusion-related malaria is unknown but
can be a contributing factor in the maintenance of disease
transmission, especially in areas where proper physical, epi-
demiological and laboratorial screenings are not performed
effectively. Because of the need to evaluate the malaria
screening process of blood donors, a study was conducted
to deﬁne the proﬁle of those seeking the HEMOAM Founda-
tion and to evaluate the performance of immunochromatic
antigen-based rapid tests as a diagnostic tool.
Methods
A cross-sectional descriptive study was performed in blood
donors with a history of exposure to malaria and the perfor-
mance of two immunochromatic antigen-based rapid tests
were evaluated in respect to screening potential donors in
HEMOAM. Convenience sampling was employed to include
potential donors that during the clinical screening and inter-
view presented a history of possible exposure to malaria. The
study enrolled 407 blood donor candidates between May 2008
and May 2009. The individuals were divided in two groups
according to their level of risk (eligible and ineligible to donate
blood) based on the API established by the Fundac¸ão de Vig-
ilância em Saúde do Amazonas (FVS-AM). Group 1 (eligible)
consisted of potential donors originating from areas of low
to medium risk of exposure and Group 2 (ineligible) com-
prised of potential donors originating from high-risk areas.
Donor candidates that were ineligible due to reasons other
than risk of malaria were not included in this study. During
the screening process at HEMOAM, potential donor candidates
were approached and invited to participate in the study. Upon
acceptance, all signed informed consent forms. This research
was approved by the Ethics Committee of HEMOAM (#154985).
Subsequently, a questionnaire was completed on the
demographic (gender, age), socioeconomic (geographic origin
and education level) and epidemiological (history of previous
malaria infection, visits to areaswith risk ofmalaria transmis-
sion and place of residence) aspects of participants.
Eligible donors were sent to the blood collection room
where a 5mL whole blood sample was collected in a labeled
®aminetetraacetic acid (EDTA: BD, USA). Ineligible donors were
taken to the clinical analysis laboratory to undergo blood
collection using the same procedure. At the time of blood
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ollection, two thick smear slides were prepared using periph-
ral capillary blood collected from a ﬁnger prick according to
orld Health Organization (WHO) guidelines and evaluated
y two experienced technicians from the District III Labo-
atory for Endemic Disease Control of FVS-AM. Additional
alaria testing was performed using two immunochromatic
ntigen-based rapid tests: OptiMal® (DiaMed, Switzerland), a
outine test at FHEMOAM, and SD Bioline Malaria Antigen®
Standard Diagnostics, INC, Korea). These tests detect the
resence of Plasmodium lactate dehydrogenase (PLDH) using
onoclonal and polyclonal antibodies, respectively. All essays
ere performed following the speciﬁcations of the manufac-
urers. Statistical analysis utilized the EpiInfoTM (version 3.5)
omputer program; the Pearson chi-square test was used to
ompare categorical data and Student’s t-test was used to
ompare means. The level of signiﬁcance was set at 5% (p-
alue<0.05).
esultsuring the study period, 44,117 candidates went to HEMOAM
o donate blood. After clinical and epidemiological screening,
3,317 were considered eligible for donation and 10,800 were
Table 1 – The sociodemographic proﬁle of blood donor candida
Group
I (eligible)
(n=265)
Gender – n (%)
Male 207 (66.1)
Female 58 (61.7)
Age (years) – n (%)
18–29 123 (62.4)
30–39 81 (72.3)
40–49 43 (63.2)
50–59 15 (60.0)
60 or more 5 (100.0)
Mean±SD 31.6±10.2
Range 18–65
Schooling – n (%)
Illiterate 1 (100.0)
Basic education 1 (50.0)
Junior School 36 (56.2)
High School 157 (68.2)
College 72 (65.4)
Origin – n (%) (geographic region)
North 70 (68.0)
East 27 (51.9)
West 54 (77.1)
Central-west 38 (53.5)
South 41 (70.7)
Central-South 32 (68.1)
Rural 3 (50.0)
SD: standard deviation.
#: Grades 1-9 as established by the Brazilian Department of Education. &: H
a Pearson’s Chi-square.
b Student’s t-test for means.
c Unable to perform testing due to Chi-square restrictions (Vieira, 2004).14;36(4):269–274 271
considered ineligible for differing reasons. Of 667 eligible
donors, 265 agreed to participate in the study (Group 1). Of
the ineligible donors, 2455 (22.7%) were not allowed to donate
because they originated from high-risk areas for malaria
transmission based on the API, and 142 consented to partic-
ipate in this study (Group 2). Thus a total of 407 individuals
were enrolled.
All samples were evaluated using the two immunochro-
matic antigen-based rapid tests and the thick smear test;
results were negative in all three tests. Proﬁle analysis of the
donor candidates by groups (Table 1) showed that the only
signiﬁcant difference between the two groups (p-value=0.023)
occurredwhen the residencewithin and around theMunicipal
of Manaus was considered; 68% (70/103) of candidates orig-
inating from the northern region of Manaus were in Group
1 and 32% (33/103) in Group 2. Table 1 also shows a preva-
lence of men, and candidates between the ages of 18 and 29 in
both groups. Additionally, themajority of candidateshad com-
pleted high school or college level education in both groups.
Candidates were also asked about their blood donation
experience and travel history within and outside of Manaus
(Table 2). When asked if they were donating blood for the
ﬁrst time, 155 out of 407 participants answered “yes”; with
59.3% (92/155) of the eligible and 40.7% (63/155) of the ineligible
tes according to the risk of exposure to malaria.
Total p-valuea
II (ineligible)
(n=142)
106 (33.9) 313 0.429
36 (38.3) 94
0.620b
74 (37.6) 197
31 (27.7) 112
25 (36.8) 68
10 (4.0) 25
– 5
31.1±10.1
20–59
c
– 1
1 (50.0) 2
28 (43.8) 64
73 (31.8) 230
38 (34.6) 110
0.023
33 (32.0) 103
25 (48.1) 52
16 (22.9) 70
33 (46.5) 71
17 (29.3) 12
15 (31.9) 47
3 (50.0) 6
igh School as established by the Brazilian Department of Education.
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Table 2 – Clinical and epidemiological data of blood donor candidates in Group I (eligible) and Group II (ineligible).
Group Total p-Valuea
I (eligible)
(n=265)
n (%)
II (ineligible)
(n=142)
n (%)
Is this your ﬁrst donation? 92 (59.4) 63 (40.6) 155 0.056
Did you know about malaria transmission? 228 (67.5) 110 (32.5) 338 0.028
Did you do any type of prophylaxis? 117 (66.5) 59 (33.5) 176 0.613
Are there cases of malaria where you live? 52 (56.5) 40 (43.5) 92 0.074
Have you had fever in the last 30 days? 5 (50.0) 5 (50.0) 10 0.243
Have you had malaria before? 55 (63.2) 32 (36.8) 87 0.676
Time of disease 0.603b
Mean± standard deviation 86.7±111.7 98.3±71.4
Range 12–480 24–240
Have you traveled in the last 30 days? 88 (40.2) 131 (59.8) 219 <0.001
Do you know if there are cases of malaria where you went? 45 (48.9) 47 (51.1) 92 0.092
Did you visit any neighborhood different to here you live? 44 (66.7) 22 (33.3) 66 0.771
Did you sleep in this neighborhood? 10 (52.6) 9 (47.4) 19 0.242
Have you ever received a blood transfusion? 5 (45.5) 6 (54.5) 11 0.143a Pearson’s Chi-square.
b Student’s t-test for means
donors, there was a signiﬁcant difference between the two
groups (p-value=0.056). reported by 87 of the 407 candidates,
63.2% (55/87) were from the eligible group and 36.8% (32/87)
from the ineligible group (non-signiﬁcant difference); how-
ever, all of the ineligible candidates reported traveling outside
of Manaus within the 30 days preceding the interview (p-
value<0.001).
Discussion
Malaria is a reason for a continuous state of alert during blood
donor screening, especially in endemic areas. Blood donation
eligibility in Brazil takes into consideration the risk of expo-
sure to malaria as measured by the API of the geographic
region where blood donor candidates originate. In this study
we evaluated a sample of potential blood donors, clinical
and epidemiological data were collected and individuals were
tested formalaria using two immunochromatic antigen-based
rapid tests and the gold standard to diagnose malaria, the
thick smear test. In this study there were no positive results
for malaria among both eligible and ineligible candidates.
Even though the thick blood smear is the gold standard,
it requires time and expertise, especially when the parasite
blood levels are low.11 Operational issues became an obstacle
in the use of microscopy in the routine screening of poten-
tial donors in blood banks serving large populations and with
a high throughput of samples.10,11 In 2010, Ali et al. in a
study carried out in Pakistan, tested 1558 blood donors using
microscopy to diagnose malaria, and found nine (0.577%) pos-
itive tests.13 However, this is not a viable approach formedium
and large donation centers.
The immunochromatic antigen-based rapid malaria tests
have been developed because of the need of fast and accu-
rate results.10 Some of these methods utilize monoclonal
and polyclonal antibodies directed against the P. falciparum
histidine-rich protein 2 (PfHRP-2) and against the Plasmodiumlactate dehydrogenase (PLDH) of four Plasmodium species.11
These are rapid and efﬁcient tests but lack the ability to diag-
nose mixed infections and present limited sensitivity when
parasite levels are low.10
In 2007, Ratsimbasoa et al. compared the rapid tests,
SD Malaria, OptiMAL and CareStart, against the thick blood
smear in samples from an endemic area in Madagascar. The
sensitivity for P. falciparum was 89.4%, 92.6% and 97%, respec-
tively. All three tests were less sensitive in non-endemic areas
for P. falciparum and when parasite levels were less than
500 parasites/L of blood.14 Contreras et al. emphasize that,
despite uncommon,malaria cases resulting from transfusions
are usually lethal, and, in endemic areas, transfusion-related
malaria is indistinguishable from natural malaria infection.
Individuals presenting asymptomatic infection by Plasmodium
parasites represent a risk for transfusion-related transmis-
sion; these are usually cases with low parasite levels that are
undetected in the screening process using less sensitive labo-
ratory tests.7,15
Many people refused to participate due to the inconve-
nience of having to collect blood to test for malaria; the
ﬁnger prick is considered painful, and even though candidates
voluntarily offered to donate blood, they were unwilling to
participate in this study.
In this study, there was a prevalence of men in both groups,
a characteristic observed in many blood banks in Brazil.13 The
mean age of candidates was 31 years, ranging from 18 to 65 in
Group 1 and from20 to 59 in Group 2; 48%were between 18 and
29, an age that many individuals participate in outdoor activ-
ities common to the Amazon region which increase the risk
of exposure to the disease. These activities include manda-
tory military service which often entails staying inside the
forest. Also, the younger Brazilian population is more open to
new ideas and is becoming more active and involved in social
programs such as blood donation.13
Education is a deciding factor in enrolling and maintain-
ing donors, as well as establishing the role of a citizen and a
er. 20
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ocially responsible individual.16 In this study 56.5% had high
chool diplomas [157/230 (68.2%) in Group 1 and 73/230 (31.8%)
n Group 2] and another 27% had college education [72/110
65.4%) in Group 1 and 38/110 (34.6%) in Group 2].We speculate
hat this population has been exposed to a level of knowledge
hat breaks the taboos associated with blood donation often
ound in developing countries,23,24 and we hope that as edu-
ation improves in Brazil more people will volunteer to donate
lood.
The incidence of malaria in the Amazon Region has sea-
onal ﬂuctuations. In this region the temperature is stable,
ut the rainfall and humidity vary during the year and
alaria transmission follows a pattern associated with the
easons.16,17 In our study, potential donors were selected
hroughout the year but no positive samples were detected,
e understand that the small study size and convenience
ampling may have inﬂuenced this result and only a larger,
ore structured study would help to ﬁnd the real incidence of
alaria infection within potential blood donors.
The current criteria of eligibility for blood donation based
n the patient’s origin and visits to a high-risk area have a
egative impact on the supply of blood and blood related prod-
cts. In the Unites States, the ineligibility of donors related
o visiting malaria endemic areas has been questioned and it
as been demonstrated that the screening criteria should be
eassessed due to the impact on the blood supply.18
Manaus is divided into six city zones; North, East, West,
entral-west, South, Central-south and the rural area. In
his study, there was a statistically signiﬁcant difference in
he geographic region of the houses of potential donors (p-
alue<0.001), with 68% (70/103) of eligible and 32% (33/103)
f ineligible living in the North of the city. This data corre-
ates with the origin of patients with malaria diagnosed and
otiﬁed by the Foundation of TropicalMedicine from theAma-
onas where the majority comes from West, East, North and
ural areas of Manaus,19 where there is a high concentration
f population settlements and disorderly occupations of land.
We found that 56.5% (230/407) of the study participants vis-
ted high risk areas for the transmission of malaria within 30
ays prior to volunteering to donate blood; 61.7% (142/230) of
hesewere inGroup2; individualswhovisit these areas cannot
onate blood. We also discovered that three candidates had
history of malaria within 12 months of offering to donate
lood and that ﬁve had fever within 30 days prior to their
isit to donate blood. These individuals were considered ﬁt
o donate by routine screeners when they should have been
onsidered ineligible. This demonstrates that the screening
rocess is not error-proof, and even with a negative result in
ll three tests, this fact supports the need for a better, more
igorous screening process and also the need of tests sensitive
nough to detect low parasite levels.
Many previous reports have emphasized the use of
olecular techniques, especially DNA ampliﬁcation using
olymerase chain reaction (PCR), which has higher sensitivity
han other methods, including the thick blood smear, the cur-
ent gold standard.20,21 In 2006, Torres et al. diagnosed, using
CR, one patient with P. vivax DNA among 11 cases who pre-
ented symptoms for the disease but had negative parasite
xams. Fugikahaet al. evaluated the frequencyof blooddonors
nfected with malaria in four blood banks in areas within the14;36(4):269–274 273
Brazilian Amazon. Of the 400 donors submitted to nested-
PCR evaluations, ninewere positive formalaria, revealing high
positivity, varying from 1 to 3%, for blood donors in the four
centers.22
Conclusion
In this study, all samples tested using the rapid immunochro-
matic antigen-based malaria tests, OptiMal® and SD Bioline
Malaria Antigen® and the thick blood smear, the gold standard
to diagnose malaria, were negative and so no signiﬁcant dif-
ference in sensitivity or speciﬁcity was found.
The majority of the donor candidates were male, young
adults, had either high school or college education and origi-
nated from the northern region of Manaus.
More research including the use of molecular biology tech-
niques are needed to evaluate the risk of transfusion-related
malaria transmission, with the ultimate goal of reviewing
the guidelines of the screening process in hematology and
hemotherapy services in endemic areas.
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